WallStSmart

Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW)vsThermo Fisher Scientific Inc (TMO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Thermo Fisher Scientific Inc generates 1649% more annual revenue ($44.56B vs $2.55B). TMO leads profitability with a 15.0% profit margin vs -106.0%. TMO earns a higher WallStSmart Score of 59/100 (C).

PSNYW

Avoid

34

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 5.0Quality: 5.0

TMO

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 7.3Quality: 6.3
Piotroski: 3/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for PSNYW.

TMOSignificantly Overvalued (-27.5%)

Margin of Safety

-27.5%

Fair Value

$384.82

Current Price

$490.77

$105.95 premium

UndervaluedFair: $384.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PSNYW1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
26.1%8/10

Revenue surging 26.1% year-over-year

TMO3 strengths · Avg: 8.3/10
Market CapQuality
$182.14B9/10

Large-cap with strong market position

Operating MarginProfitability
21.2%8/10

Strong operational efficiency at 21.2%

Free Cash FlowQuality
$2.99B8/10

Generating 3.0B in free cash flow

Areas to Watch

PSNYW4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-292.84M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-106.0%1/10

Currently unprofitable

TMO3 concerns · Avg: 3.7/10
PEG RatioValuation
1.764/10

Expensive relative to growth rate

P/E RatioValuation
27.6x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : PSNYW

The strongest argument for PSNYW centers on Revenue Growth. Revenue growth of 26.1% demonstrates continued momentum.

Bull Case : TMO

The strongest argument for TMO centers on Market Cap, Operating Margin, Free Cash Flow.

Bear Case : PSNYW

The primary concerns for PSNYW are EPS Growth, Return on Equity, Free Cash Flow.

Bear Case : TMO

The primary concerns for TMO are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

PSNYW profiles as a growth stock while TMO is a value play — different risk/reward profiles.

PSNYW carries more volatility with a beta of 1.65 — expect wider price swings.

PSNYW is growing revenue faster at 26.1% — sustainability is the question.

TMO generates stronger free cash flow (3.0B), providing more financial flexibility.

Bottom Line

TMO scores higher overall (59/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

Polestar Automotive Holding UK PLC (Ticker: PSNYW) is a leading contender in the electric performance vehicle market, distinguished by its commitment to innovation and sustainability. As a subsidiary of Volvo Cars and Geely, Polestar leverages cutting-edge technology and engineering to create high-performance electric vehicles, exemplified by its flagship model, the Polestar 2, which integrates exceptional design with advanced connectivity features. The company is strategically enhancing its global presence and production capabilities, positioning itself to capitalize on the rapid growth of the electric vehicle sector and play a pivotal role in the transition towards a sustainable automotive future.

Thermo Fisher Scientific Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Visit Website →

Want to dig deeper into these stocks?